May 31, 2024, 10:51
Yüksel Ürün on CheckMate 901 trial
Yüksel Ürün shared a post on X:
“CheckMate 901 trial: Abstract #4509
For lymph node-only mUC, NIVO+GC resulted in durable disease control and significant OS and PFS improvements. Proud to have played a role in this impactful study.”
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 28, 2024, 12:21
Sep 28, 2024, 12:05
Sep 28, 2024, 10:00
Sep 28, 2024, 08:49
Sep 28, 2024, 08:41